InSilico Medicine Cayman TopCo (HKG:3696)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
64.30
+2.10 (3.38%)
At close: Apr 29, 2026

HKG:3696 Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Net Income
--17.1-211.64-221.83
Depreciation & Amortization
-6.054.481.78
Loss (Gain) From Sale of Assets
--0.012.19
Loss (Gain) From Sale of Investments
--0.56-0.451.04
Stock-Based Compensation
-3.2610.7912.92
Provision & Write-off of Bad Debts
--0.01-0.160.23
Other Operating Activities
--15.91122.23138.53
Change in Accounts Receivable
-2.862.11-5.95
Change in Accounts Payable
-0.299.1412.69
Change in Unearned Revenue
--35.5637.435.03
Change in Other Net Operating Assets
--0.73-3.525.84
Operating Cash Flow
--57.4-29.58-47.52
Capital Expenditures
--0.84-2.56-10.98
Sale of Property, Plant & Equipment
--0.01-
Divestitures
----2.22
Sale (Purchase) of Intangibles
--0.08-0.41-0.24
Other Investing Activities
-8.353.66-0.15
Investing Cash Flow
-7.420.69-13.58
Long-Term Debt Repaid
--1.56-1.4-0.97
Net Debt Issued (Repaid)
--1.56-1.4-0.97
Issuance of Common Stock
-0.410.010.21
Other Financing Activities
--0.38-0.79-1.83
Financing Cash Flow
--1.54-2.18107.15
Foreign Exchange Rate Adjustments
-0.280.370.29
Net Cash Flow
--51.24-30.746.34
Free Cash Flow
--58.25-32.14-58.5
Free Cash Flow Margin
--67.86%-62.79%-194.03%
Free Cash Flow Per Share
--0.81-0.48-0.87
Cash Interest Paid
-0.090.090.1
Levered Free Cash Flow
--56.4128.96-
Unlevered Free Cash Flow
--56.34129.02-
Change in Working Capital
--33.1445.1617.62
Source: S&P Capital IQ. Standard template. Financial Sources.